Support-t Online Training for Type 1 Diabetes Transition Care
(Support-t Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on online training and support, so it's likely you can continue your usual diabetes care.
What data supports the effectiveness of the treatment Support-t Online Training for Type 1 Diabetes Transition Care?
How is the Support-t Online Training treatment for Type 1 Diabetes unique?
Support-t Online Training is unique because it focuses on helping young adults transition from pediatric to adult diabetes care, aiming to improve clinic attendance, diabetes control, and reduce hospital admissions. Unlike traditional treatments that focus solely on medical management, this program provides structured support during a critical life stage, addressing both medical and psychosocial needs.678910
What is the purpose of this trial?
The investigators will conduct a randomized controlled trial (RCT) to examine how an online training and peer support platform could help the preparation to transition to adult care. Among 14-16 year old youth with Type 1 Diabetes (T1D), the investigators aim to assess the effect of an online training and peer support platform (Support-t) integrated in usual care, compared with usual care on Hemoglobin A1c (HbA1c), adverse outcomes and psychosocial measures during the preparation for transition to adult care. The investigators will conduct a multi-site, parallel group, blinded (outcome assessors, data analysts), superiority RCT of adolescents with T1D (14-16 years of age) followed at one of 4 university teaching hospital-based pediatric diabetes clinics in the province of Quebec.
Research Team
Anne-Sophie Brazeau, PhD
Principal Investigator
School of Human Nutrition - McGill University
Eligibility Criteria
This trial is for 14-16 year olds with Type 1 Diabetes who are patients at one of four specific pediatric diabetes clinics in Quebec. They must have internet access, an active email, and speak English or French. It's not specified who can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive access to the Support-t online training and peer support platform in addition to usual diabetes care
Follow-up
Participants are monitored for changes in HbA1c and other secondary outcomes
Post-study Access
Control group participants have the option to use the Support-t platform after the 18-month study
Treatment Details
Interventions
- Support-t
Support-t is already approved in Canada for the following indications:
- Type 1 Diabetes Transition Support
Find a Clinic Near You
Who Is Running the Clinical Trial?
Anne-Sophie Brazeau
Lead Sponsor
McGill University
Lead Sponsor
CHU de Quebec-Universite Laval
Collaborator
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborator
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Collaborator
CSSS de Gatineau
Collaborator